| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Sensei Biotherapeutics Inc (NASDAQ: SNSE)
SNSE Technical Analysis
5
| As on 9th Jun 2023 SNSE STOCK Price closed @ 1.35 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.57 & Strong Sell for SHORT-TERM with Stoploss of 4.75 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SNSESTOCK Price
| Open | 1.37 | Change | Price | % |
| High | 1.39 | 1 Day | -0.02 | -1.46 |
| Low | 1.35 | 1 Week | -0.11 | -7.53 |
| Close | 1.35 | 1 Month | -0.12 | -8.16 |
| Volume | 16169 | 1 Year | -4.70 | -77.69 |
| 52 Week High 6.07 | 52 Week Low 1.31 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SNSE Daily Charts |
SNSE Intraday Charts |
Whats New @ Bazaartrend |
SNSE Free Analysis |
|
|
SNSE Important Levels Intraday
| RESISTANCE | 1.43 |
| RESISTANCE | 1.40 |
| RESISTANCE | 1.39 |
| RESISTANCE | 1.37 |
| SUPPORT | 1.33 |
| SUPPORT | 1.31 |
| SUPPORT | 1.30 |
| SUPPORT | 1.27 |
SNSE Forecast May 2024
| 4th UP Forecast | 4.66 |
| 3rd UP Forecast | 3.6 |
| 2nd UP Forecast | 2.94 |
| 1st UP Forecast | 2.29 |
| 1st DOWN Forecast | 0.41 |
| 2nd DOWN Forecast | -0.24 |
| 3rd DOWN Forecast | -0.9 |
| 4th DOWN Forecast | -1.96 |
SNSE Weekly Forecast
| 4th UP Forecast | 4.80 |
| 3rd UP Forecast | 3.69 |
| 2nd UP Forecast | 3.01 |
| 1st UP Forecast | 2.33 |
| 1st DOWN Forecast | 0.37 |
| 2nd DOWN Forecast | -0.31 |
| 3rd DOWN Forecast | -0.99 |
| 4th DOWN Forecast | -2.10 |
SNSE Forecast2024
| 4th UP Forecast | 11.39 |
| 3rd UP Forecast | 8.17 |
| 2nd UP Forecast | 6.18 |
| 1st UP Forecast | 4.19 |
| 1st DOWN Forecast | -1.49 |
| 2nd DOWN Forecast | -3.48 |
| 3rd DOWN Forecast | -5.47 |
| 4th DOWN Forecast | -8.69 |
Sensei Biotherapeutics Inc ( NASDAQ USA Symbol : SNSE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SNSE Business Profile
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, engages in the discovery and development of therapies with an initial focus on treatments for cancer. The company develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response. It is engineering ImmunoPhage product candidates to directly target antigen presenting cells and modulate the tumor microenvironment through the targeted use of nanobodies which further enhances therapeutic activity. Sensei Biotherapeutics, Inc. was formerly known as Panacea Pharmaceuticals, Inc. The company was founded in 1999 and is headquartered in Rockville, Maryland. Address: 1405 Research Boulevard, Rockville, MD, United States, 20850
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service